CLOUDR: ANNUAL REPORT 2024

HKEXApr 28 17:06 · Announcements

Zhi Yun Health (09955.HK) sells equity stakes in five subsidiaries.

Zhiyun Health (09955.HK) announced that its wholly-owned subsidiaries Hangzhou Kangsheng, Jiangsu Zhiyun and 91 Health Shanghai, on the previous day (30th), entered into share transfer agreements with different buyers to sell equity in 5 subsidiaries, involving a total of 79.5164 million yuan. Among them, Hangzhou Kangsheng intends to sell all 55% of its equity in Qilian Pharmaceutical to Qilian Medical Management for 33.5164 million yuan. Hangzhou Kangsheng also entered into a share transfer agreement with Zhu Qiuna to sell 30% of its equity in New Wange Medical Technology for 32 million yuan. After the sale is completed, Hangzhou Kang.

AASTOCKSMar 31 10:52

Fully commit to embracing the AI new era, Zhiyun Health (09955) Global Strategy Upgrade 2.0.

Under the guidance of the two major strategies of "Hospital First" and "P2M", in 2024, Zhiyun Health's in-hospital and out-of-hospital solution Business achieved high-quality development.

Zhitong FinanceMar 31 09:00

The new ecology of fiery forging: The "Medical AI + P2M" evolution of Zhi Yun Health (9955.HK) 2.0.

Nowadays, the Medical Industry is at a crossroads of transformation. Driven by both policy guidance and the integration of "AI+" technologies, the industry maintains an overall positive development tone, yet a deep reconstruction of the underlying ecosystem has quietly begun. It is undeniable that the entire Medical industry ecosystem still faces many uncertainties, such as the pressure from the healthcare payment system forming a forcing mechanism and the chain reactions brought about by price adjustments in centralized procurement policies, all of which are being transmitted deeply through the Industry Chain, leading to structural changes in every segment of the industry. In this macro environment, as the trend of population aging becomes increasingly serious, payers, service providers, and suppliers are forming.

Gelonghui FinanceMar 31 08:53

In the performance report, Zhiyun Health (09955.HK) posted an annual loss that expanded to 0.516 billion yuan.

Zhi Yun Health (09955.HK) announced its full-year results for the year ended December last year, with a revenue of 3.488 billion yuan (RMB), down 5.5% year-on-year. Losses widened to 0.516 billion yuan, compared to a loss of 0.323 billion yuan in the same period last year; loss per share is 0.89 yuan. No dividend was declared.

AASTOCKSMar 30 20:34

ZhiYun Health (09955) exhibits effective results from its AI-driven Global Strategy upgrade with a revenue of 3.49 billion yuan in 2024.

Annual revenue reached 3.49 billion yuan, with a gross margin remaining stable and slightly increasing to 24.7%.

Zhitong FinanceMar 30 20:20